跳至主要内容
临床试验/NCT07095699
NCT07095699尚未招募不适用

An Exploratory, Parallel Controlled Study to Explore the Effectiveness of Intraoperative Margin Exploration Techniques for Adenocarcinoma of the Esophagogastric Junction

Fudan University0 个研究点目标入组 314 人开始时间: 2025年8月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
314
主要终点
Accuracy

研究概览

简要总结

The goal of this clinical trial is to learn if the EndoScell Scanner (ES) imaging system can accurately assess tumor-free surgical margins during surgery for adenocarcinoma of the esophagogastric junction (AEG), compared with standard frozen-section pathology.

The main questions it aims to answer are:

  • Is ES non-inferior to intraoperative frozen-section pathology in identifying positive or negative tumor margins?
  • Does ES shorten the time needed for margin assessment and reduce the number of additional tissue resections required?

Researchers will compare an ES-assisted surgical arm with a conventional frozen-section arm to see if ES improves margin accuracy, shortens operative time, and increases the rate of complete (R0) tumor removal.

Participants will

  • undergo standard AEG resection with randomized assignment to either ES or frozen-section margin checks;
  • allow collection of margin tissue samples for ES, frozen-section, and final paraffin pathology;
  • attend routine follow-up visits for up to 2 years to monitor for local recurrence.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients clinically diagnosed with adenocarcinoma of the esophagogastric junction (AEG):
  • Including patients with Siewert type II and III AEG; Including patients in cT1 stage (recommended esophageal resection margin distance ≥1.5cm) and cT2 and above (recommended esophageal resection margin distance ≥3cm);
  • Plan to receive surgical resection of AEG;
  • Patients voluntarily participated in this study and signed the informed consent form;

排除标准

  • Patients who are allergic to methylene blue and fluorescein sodium;
  • Patients with severe cardiovascular or circulatory system diseases and cannot tolerate surgery;
  • Participated in other clinical trials of research drugs or devices in the past month;
  • Unable to understand the test requirements or unable to complete the study follow-up plan;
  • Pregnant and lactating women;
  • Patients who are unable to complete follow-up due to mental illness, cognitive or emotional disorders;
  • Subjects who are considered by the researchers to be unsuitable for participating in the study.

结局指标

主要结局

Accuracy

时间窗: intraoperative

Using paraffin pathology as the gold standard, the accuracy of ES system and frozen pathology for AEG resection margin was evaluated: Accuracy Rate = true positive + true negative/total number of samples.

次要结局

  • Evaluation of the consistency between ES technique and frozen pathology(7days after the surgery)
  • Postoperative recurrence: evaluate the anastomotic recurrence rate at 6, 12 months, and 2 years after surgery(6, 12 months, and 2 years after surgery)
  • Evaluation of the time efficiency of ES and frozen pathology(7days after the surgery)
  • Evaluate the number of timely adjustments to the resection range due to the interpretation of ES technology;(7days after the surgery)
  • Evaluation of R0 resection rate(7days after the surgery)
  • Positive margin rate(7days after the surgery)
  • Evaluation of the actual resection margin distance during ES-assisted AEG(7days after the surgery)
  • Evaluate the sensitivity, specificity, PPV, and NPV of ES technology(7days after the surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fenglin Liu

senior doctor

Fudan University

相似试验